TBPH - Theravance Biopharma, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 9.46

Open

$ 9.44

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 9.30 - $ 9.48

52 Week Range

$ 8.21 - $ 11.98

Volume

333,483

Average Volume

Market Cap

523.17M

Beta (5Y Monthly)

$ 0.43

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-01-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-06-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-08-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-26-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-08-2020	03-31-2020	10-Q
17	02-27-2020	12-31-2019	10-K
18	11-08-2019	09-30-2019	10-Q
19	08-05-2019	06-30-2019	10-Q
20	05-10-2019	03-31-2019	10-Q
21	02-28-2019	12-31-2018	10-K
22	11-08-2018	09-30-2018	10-Q
23	08-02-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	02-28-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-09-2017	06-30-2017	10-Q
28	05-10-2017	03-31-2017	10-Q
29	03-01-2017	12-31-2016	10-K
30	11-09-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	03-11-2016	12-31-2015	10-K
34	11-12-2015	09-30-2015	10-Q
35	08-13-2015	06-30-2015	10-Q
36	05-13-2015	03-31-2015	10-Q
37	03-13-2015	12-31-2014	10-K
38	11-12-2014	09-30-2014	10-Q
39	08-14-2014	06-30-2014	10-Q
40	06-24-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

BTIG Initiates Coverage On Theravance Biop...
04/12/2024 11:42:05

BTIG analyst Julian Harrison initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Buy rating and announces Price ...

Theravance Biopharma Expects Non-GAAP Loss...
02/26/2024 21:27:54

Recap: Theravance Biopharma Q4 Earnings
02/26/2024 21:10:14

Theravance Biopharma Q4 2023 GAAP EPS $(0....
02/26/2024 21:08:54

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate o...

Earnings Scheduled For February 26, 2024
02/26/2024 09:47:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on...

A Preview Of Theravance Biopharma's Earnings
02/23/2024 17:01:10

logitech-posts-q3-results-joins-coinbase-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Logitech Posts Q3 Results, Joins Coinbase ...
01/23/2024 10:04:19

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 20 points on Tuesday.

On January 12, 2024, Theravance Biopharma ...
01/16/2024 11:36:47

-8-K

why-applied-therapeutics-shares-are-trading-lower-by-over-35-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Applied Therapeutics Shares Are Tradin...
01/05/2024 18:13:57

Shares of Applied Therapeutics, Inc.

why-is-lung-disease-focused-theravance-biopharma-stock-trading-lower-today

Why Is Lung Disease Focused Theravance Bio...
01/05/2024 15:36:54

Theravance Biopharma Inc (NASDAQ: TBPH) announced results from the Phase 4 PIFR-2 study of Yupelri (revefenacin) inhalation sol...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
01/05/2024 13:05:58

Franklin Covey Shares Fall After Q1 Result...
01/05/2024 11:19:39

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.

Theravance Biopharma Announces Results Fro...
01/05/2024 11:05:04

Theravance Biopharma Said On Dec 26 Units,...
12/28/2023 11:21:01

Under Deal, Accord Granted License To Manufacture, Market Accord's Generic Version Of Yupelri In U.S. After April 23, 2039 ...

Theravance Biopharma Will Present New Ampr...
11/16/2023 11:11:29

Viatris And Theravance Biopharma Announce ...
11/13/2023 13:20:11

Top-line results from Phase III study in China demonstrate the efficacy and safety profile of YUPELRI in patients with COPD

Roblox, Under Armour, GoPro, Nuvei And Oth...
11/08/2023 16:02:42

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks reco...

Theravance Biopharma Q3 2023 GAAP EPS $(0....
11/07/2023 22:03:26

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of ...

Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Theravance Biopharma Said Co's Units, Myla...
10/30/2023 21:25:07

-8-K-8-K